Drug Manufacturers—General Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 11 |  LLY Eli Lilly and Company Common Stock | 1247.64 USD | -0.57% | +3.95% | +3.88% | +75.60% | 1.17 T USD | ||
| 20 |  JNJ Johnson & Johnson Common Stock | 273.08 USD | +1.03% | +1.73% | +4.01% | +52.14% | 658.10 B USD | ||
| 22 |  ABBV AbbVie Inc. Common Stock | 264.56 USD | -0.14% | +4.18% | +2.28% | +25.80% | 467.51 B USD | ||
| 34 |  MRK Merck & Company, Inc. Common Stock | 150.69 USD | -1.20% | +9.70% | +14.98% | +73.15% | 371.78 B USD | ||
| 43 |  NVS Novartis AG | 157.99 USD | -0.55% | +2.84% | +0.91% | +24.60% | 301.47 B USD | ||
| 59 |  AMGN Amgen Inc. - Common Stock | 443.84 USD | +1.03% | +5.27% | +17.25% | +51.68% | 239.95 B USD | ||
| 84 |  GILD Gilead Sciences, Inc. - Common Stock | 146.74 USD | +0.42% | +4.81% | +12.02% | +27.70% | 181.95 B USD | ||
| 103 |  PFE Pfizer, Inc. Common Stock | 27.98 USD | -0.32% | +3.06% | +13.88% | +8.16% | 159.48 B USD | ||
| 113 |  BMY Bristol-Myers Squibb Company Common Stock | 67.29 USD | +0.40% | +2.58% | +7.84% | +40.30% | 137.45 B USD | ||
| 139 |  GSK GSK plc American Depositary Shares | 51.80 USD | -1.18% | +2.01% | -0.46% | +18.13% | 111.77 B USD | ||
| 142 |  SNY Sanofi - American Depositary Shares | 45.69 USD | -0.35% | +1.31% | +4.48% | -10.57% | 111.43 B USD | ||
| 373 |  ONC BeOne Medicines Ltd - American Depositary Shares | 371.98 USD | -0.66% | +2.19% | +13.50% | +17.83% | 42.29 B USD | ||
| 440 |  BIIB Biogen Inc. - Common Stock | 218.12 USD | +0.62% | +3.37% | +7.58% | +56.91% | 32.23 B USD | ||
| 1127 |  CGON CG Oncology, Inc. - Common stock | 78.23 USD | -1.98% | +3.16% | +10.32% | +79.59% | 6.93 B USD | ||
| 1141 |  ORKA Oruka Therapeutics, Inc. - Common Stock | 102.42 USD | -5.13% | -7.12% | +11.69% | +219.36% | 6.78 B USD | ||
| 1500 |  MANE Veradermics, Incorporated Common Stock | 98.33 USD | -4.48% | -9.16% | -10.81% | +197.97% | 4.11 B USD | ||
| 1587 |  OGN Organon & Co. Common Stock | 13.76 USD | 0.00% | +0.36% | +1.78% | +89.53% | 3.61 B USD | ||
| 1677 |  MBX MBX Biosciences, Inc. - Common Stock | 66.39 USD | +0.09% | -0.02% | +6.67% | +365.57% | 3.20 B USD | ||
| 1892 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 49.33 USD | +2.26% | +3.18% | +20.88% | +88.35% | 2.37 B USD | ||
| 1921 |  GENB Generate Biomedicines, Inc. - Common Stock | 17.72 USD | +9.93% | +13.01% | +29.91% | +18.13% | 2.27 B USD |
Notizie Drug Manufacturers—General Stocks
+99%, +85%, +45%: I titoli value ad alta convinzione scelti dall’IA continuano a salire
Perché il titolo Eli Lilly scende oggi?
Roche ed Eli Lilly ottengono l’approvazione FDA per test sull’Alzheimer
La Commissione europea approva la combo Trodelvy-Keytruda per il TNBC
Eli Lilly lancia la pillola dimagrante Foundayo in Gran Bretagna
GSK ottiene l’approvazione in Giappone per il farmaco contro l’epatite B e avvia la revisione FDA
La FDA accetta la domanda di GSK per Jemperli nel cancro al retto
Gainers Drug Manufacturers—General Stocks
 VBIO Valion Bio, Inc. - Common stock | 0.17 | +41.67% |
GENB Generate Biomedicines, Inc. - Common Stock | 17.72 | +9.93% |
 PPCB Propanc Biopharma, Inc. - Common Stock | 1.16 | +7.41% |
 ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0600 | +6.38% |
 MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.79 | +3.95% |
 PTHS Pelthos Therapeutics Inc. Common Stock | 26.59 | +3.18% |
 DWTX Dogwood Therapeutics, Inc. - Common Stock | 2.56 | +2.81% |
 PVLA Palvella Therapeutics, Inc. - Common Stock | 145.75 | +2.61% |
Losers Drug Manufacturers—General Stocks
 KAPA Kairos Pharma, Ltd. Common Stock | 0.24 | -17.24% |
 PLYX Polaryx Therapeutics, Inc. - Common Stock | 1.87 | -9.66% |
 QCLS Q/C Technologies, Inc. - Common Stock | 2.41 | -6.59% |
 EXOZ eXoZymes Inc. - Common Stock | 6.95 | -5.83% |
 UPB Upstream Bio, Inc. - Common Stock | 6.61 | -5.16% |
ORKA Oruka Therapeutics, Inc. - Common Stock | 102.42 | -5.13% |
MANE Veradermics, Incorporated Common Stock | 98.33 | -4.48% |
 MDCX Medicus Pharma Ltd. - Common Stock | 0.26 | -3.70% |